📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Avidia

1.1 - Company Overview

Avidia Logo

Avidia

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical therapies focused on discovering and developing therapeutic proteins. Offers Avimer therapeutic proteins addressing multiple therapeutic areas, including autoimmunity, inflammation, oncology, and neurology. Founded in 2003 and headquartered in Mountain View, California.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Avidia

Symic Bio Logo

Symic Bio

HQ: United States Website
  • Description: Provider of biotechnology offerings in the healthcare industry.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Symic Bio company profile →
Bryn Pharma Logo

Bryn Pharma

HQ: United States Website
  • Description: Provider of nasal-based epinephrine for anaphylaxis, including NDS1C, a needle-free, easy-to-use epinephrine nasal spray for the treatment of anaphylaxis. Also offers a Clinical Development Program focused on demonstrating the pharmacokinetic parameters and safety of NDS1C compared to the 0.3 mg IM epinephrine autoinjector.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bryn Pharma company profile →
Step Pharma Logo

Step Pharma

HQ: France Website
  • Description: Provider of CTPS1 inhibition therapies, developing STP938, an orally bioavailable CTPS1 inhibitor in clinical development for treating blood cancers and potentially solid tumors. The approach targets the CTPS1 enzyme to inhibit a key step in nucleotide synthesis to treat various cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Step Pharma company profile →
Third Harmonic Bio Logo

Third Harmonic Bio

HQ: United States Website
  • Description: Provider of a clinical-stage, first-in-class, highly selective oral small molecule KIT inhibitor for mast cell-mediated inflammatory diseases; THB335 is being developed for chronic spontaneous urticaria, severe asthma, and other related conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Third Harmonic Bio company profile →
PvP Biologics Logo

PvP Biologics

HQ: United States Website
  • Description: Provider of a therapeutic oral enzyme for celiac disease, developing KumaMax to break down the immuno-reactive parts of gluten in the stomach to help reduce symptoms and intestinal damage.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PvP Biologics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Avidia

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Avidia

2.2 - Growth funds investing in similar companies to Avidia

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Avidia

4.2 - Public trading comparable groups for Avidia

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Avidia

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Avidia

What does Avidia do?

Avidia is a provider of biopharmaceutical therapies focused on discovering and developing therapeutic proteins. Offers Avimer therapeutic proteins addressing multiple therapeutic areas, including autoimmunity, inflammation, oncology, and neurology. Founded in 2003 and headquartered in Mountain View, California.

Who are Avidia's competitors?

Avidia's competitors and similar companies include Symic Bio, Bryn Pharma, Step Pharma, Third Harmonic Bio, and PvP Biologics.

Where is Avidia headquartered?

Avidia is headquartered in United States.

How many employees does Avidia have?

Avidia has 1,000 employees 🔒.

When was Avidia founded?

Avidia was founded in 2010 🔒.

What sector and industry vertical is Avidia in?

Avidia is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Avidia

Who are the top strategic acquirers in Avidia's sector and industry

Top strategic M&A buyers and acquirers in Avidia's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Avidia?

Top strategic M&A buyers groups and sectors for Avidia include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Avidia's sector and industry vertical

Which are the top PE firms investing in Avidia's sector and industry vertical?

Top PE firms investing in Avidia's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Avidia's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Avidia's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Avidia's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Avidia include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Avidia's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Avidia?

The key public trading comparables and valuation benchmarks for Avidia include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Avidia for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Avidia with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Avidia's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Avidia with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Avidia's' sector and industry vertical?

Access recent funding rounds and capital raises in Avidia's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Avidia

Launch login modal Launch register modal